Crispr Therapeutics AG (CRSP)

100.84
-2.70(-2.61%)
After Hours
100.10
-0.74(-0.73%)
- Real-time Data
  • Volume:
    1,370,333
  • Bid/Ask:
    100.10/101.00
  • Day's Range:
    99.02 - 104.34

CRSP Overview

Prev. Close
103.54
Day's Range
99.02 - 104.34
Revenue
1.1M
Open
101.41
52 wk Range
54.5 - 220.2
EPS
-5.62
Volume
1,370,333
Market Cap
7.64B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
1,882,539
P/E Ratio
-
Beta
2.28
1-Year Change
69.34%
Shares Outstanding
75,768,936
Next Earnings Date
Aug 11, 2021
What is your sentiment on Crispr Therapeutics AG?
or
Market is currently closed. Voting is open during market hours.

Crispr Therapeutics AG News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellBuy
Technical IndicatorsBuyStrong SellStrong SellStrong SellBuy
SummaryNeutralStrong SellStrong SellStrong SellBuy

Crispr Therapeutics AG Company Profile

Crispr Therapeutics AG Company Profile

Employees
410

CRISPR Therapeutics AG is a Switzerland-based gene-editing company. It focuses on the development of transformative gene-based medicines for serious diseases. The Company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform, which allows for precise directed changes to genomic deoxyribonucleic acid (DNA). The Company has a portfolio of therapeutic programs in a range of disease areas, including hemoglobinopathies, oncology, regenerative medicine and rare diseases. Its lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient’s hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. The Company has business operations in London and the United Kingdom, as well as research and development operations in the United States.

Read More
  • The earnings are similar to WKHS which is under 10 dollars now. This is way overhyped and overpriced. SHORT THIS STOCK! This is not the time to buy speculative stocks!!
    0
    • What stock is WKHS?
      0
    • Workhorse, Electric truck maker! It went up 40 dollars and it's around $8 range now.
      0
  • sinking
    0
    • fair price 35 dollars
      6
      • pathetic earnings, time to sell before it drops below 110
        7
        • pathetic earnings... do you even know what this company do?
          1
      • (some news from a month ago, but more than half of you probably don't even know:) FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease
        0
        • After six years of work, that experimental treatment has now been approved for clinical trials by the U.S. Food and Drug Administration, enabling the first tests in humans of a CRISPR-based therapy to directly correct the mutation in the beta-globin gene responsible for sickle cell disease. Beta-globin is one of the proteins in the hemoglobin complex responsible for carrying oxygen throughout the body.The trials, which are expected to take four years, will be led by physicians at UCSF Benioff Children’s Hospital Oakland and UCLA’s Broad Stem Cell Research Center who plan to begin this summer to enroll six adults and three adolescents with severe sickle cell disease.
          1
        • https://news.berkeley.edu/2021/03/30/fda-approves-first-test-of-crispr-to-correct-genetic-defect-causing-sickle-cell-disease/
          0
        • oh some of us know....this is a multi decade play pay and walk away....someday it will be $4k a share
          1
      • this will be a good buy when it reaches 50....pre bubble price
        4
        • Going to $75 after earnings
          4
          • earnings will be lossses
            0
        • Today, CRISPR Therapeutics and Vertex Pharmaceuticals announced that the companies have amended their collaboration agreement for our investigational CRISPR/Cas9 gene-editing program for severe hemoglobinopathies
          0
          • The price won't drop below this line. (and when you put the graph in log scale you can also make a long term bull channel that fits the support line even better)
            1
            • then show me your chart. I'll wait.
              0
            • I dont know how to attach charts here using mobile phone, but the line should touch the bottoms created between 08/17 and 12/18 in your chart.
              0
            • couldn't find it. I'll wait for your chart if you get on a pc one day.
              0
          • "Earnings" will confirm and justify the drop from 220, and will further justify a much lower share price. Good luck!
            3
            • Recent funding news has redirected my thoughts. This could be pretty good news long term if you have the will.Congrats to the holders, you could be rewarded long term. Good Luck!
              0
          • Collapse to 76-77
            5
            • Are you shorting now ?
              1
            • if interest rates go above 2.2 %...this wil be at 30 dollars
              1
            • Gap still not filled. Technicals still show 85-90 being support after the 110 is broken. This could easily retrace to mid/low double digits.40's by end of summer is very plausible.
              1
          • Guys....be in at 80 and DCA down to about 40 .....then buy and hold forever
            1
            • I was originally thinking 50 was a good entry. but I'm liking 40 much better.
              2
          • you've all been pumped. how'd it feel? the pain hasn't even started. was thinking I'd pick some up sub 100. may consider sub 50. go ahead , down vote into oblivion. see you at the bottom.
            5
            • Its alright. Anyone who isnt leveraging and can afford to freeze that money is doing fine. But no, it wasnt a pump and dump, alot of micro and small caps have fallen 50%, which is alright if u can hold. I will probably invest more in the days to come.
              0
            • Its alright. Anyone who isnt leveraging and can afford to freeze that money is doing fine. But no, it wasnt a pump and dump, alot of micro and small caps have fallen 50%, which is alright if u can hold. I will probably invest more in the days to come.
              0
          • Started buying $500 per month starting this month. Plan on buying $500 worth every 21st of the month until Jan 2023. Perfect hold forever type of stock
            0
            • United States doesn't belive in cures. this company will be purchased by a foreign counterpart or the likes of US billionaires in the kahootz with big pharma will NEVER let crsp be nothing more than a "wish". but keep dreaming and buying
              2
            • Val Venus You literally have a comment saying you're buying at $50... If you're right I will also be buying at $50... You sound like an ignorant kid
              0
          • it's turning around.
            3
            • BUY THIS! You'll regret in 5-10 years if you didn't buy this dip.
              2
              • will go lower than 75
                2
              • this is fair, just wait until next "earnings". Could be easy sub 75. Zero value in this for at least a decade, and very weak technicals. Any talk of this company as an investment over a trade near term has disposable income
                0
              • Well below 100. Zero justification to be at these prices. Those in the ARKK cult, open your eyes. ARKK average share price is $44
                0
            • Biden voters, you wanted this🤮
              9
              • 🤢🤮
                0
            • support at 110 will be broken. last post on this board. been getting thumbs down all the way down from 200.enjoy the ride.
              8
              • I watched it go all the way down. I'll consider adding more sub 100. Good luck to you as well!
                1
            • At 91 there is a strong resistance point at 123 there is another if you want to invest dont do it at once but in different parts i would wait a little bit if it still can hold the upward trend i would invest otherwise at my said resistance points
              2
              • don't put a dime in above 100
                5
              • It clearly broke the yearly uptrend. Its on downtrend for months.
                2
              • Agreed
                1
            • $90 here we come!!
              7
              • lower
                4
            • Looking sick. 115-110It’s coming
              5
              • Very disappointing
                5
                • today I was tempted to buy a bit more
                  1
                  • There is a rough head-and-shoulders pattern. if it drops at all, it ll go likely 110. If not the 145 ish will continue with lower highs until a break in maybe a week or more. Just a guess. Go Long anyway , buy more if it drops further. Always keep a few K extra for these 'events'. Nothing changed except extra shares so this was to be expected..
                    2
                    • if it breaks 140, next support is 110
                      3
                      • no worries if you're long term. if you are a trader, you better lock in gains. its going lower
                        2
                      • 85'ish when 110 breaks
                        1
                      • Great predictions! Nice calls!
                        0
                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.